Announce Date | 02/20/2025 |
EPS Normalized Actual | $12.61 (Beat by $2.4) |
EPS GAAP Actual | $12.61 (Beat by $2.4) |
Revenue Actual | $6.059B |
Revenue Surprise | Beat by $6059M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $10.95792 |
EPS GAAP Estimate | $10.95792 |
Revenue Estimate | $5.085217497B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 125.93232 | 16.67 | 117.7912 | 133.97792 | 8 |
Dec 2027 | 0 | INF | 0 | 0 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 12.6 | 12.6 | 6.059B | 29.67% | 6059M |
FQ3 2024 (Sep 2024) | 7.831 | 7.831 | 4.76B | 28.17% | 4760M |
FQ2 2024 (Jun 2024) | 0 | 0 | 4.592B | 25.63% | 4592M |
FQ1 2024 (Mar 2024) | 6.79 | 6.79 | 4.333B | 36.23% | 4333M |
FQ4 2023 (Dec 2023) | 3.25 | 3.25 | 4.261B | 55.25% | 4261M |
FQ3 2023 (Sep 2023) | 0 | 0 | 3.419B | 28.72% | 3419M |
FQ2 2023 (Jun 2023) | 5.22 | 5.22 | 3.415B | 31.71% | 3415M |
FQ1 2023 (Mar 2023) | 0 | 0 | 2.763B | 100% | 2763M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
10.95792
Consensus Revenue Estimates
5.085217497B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 18.93825 | -- | 17.21433 | 19.89927 | 1 |
FQ2 2027 (Jun 2027) | 19.2023 | -- | 17.45434 | 20.17671 | 1 |
FQ1 2027 (Mar 2027) | 14.46211 | -- | 13.14564 | 15.19598 | 1 |
FQ4 2026 (Oct 2026) | 15.98716 | -- | 15.54184 | 16.60107 | 3 |
FQ3 2026 (Jul 2026) | 14.12663 | -- | 13.73313 | 14.6691 | 4 |
FQ2 2026 (Jun 2026) | 0 | -- | 0 | 0 | 1 |
FQ1 2026 (Mar 2026) | 0 | -- | 0 | 0 | 1 |
FQ4 2025 (Oct 2025) | 11.96723 | -5.29 | 11.63388 | 12.42678 | 3 |
FQ3 2025 (Jul 2025) | 10.55851 | 25.83 | 10.2644 | 10.96396 | 3 |
FQ2 2025 (Jun 2025) | 10.95792 | -- | 10.31756 | 11.75346 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 8.33B | -- | 7.75B | 8.66B | 3 |
FQ2 2027 (Jun 2027) | 8.09B | -- | 7.52B | 8.41B | 3 |
FQ1 2027 (Mar 2027) | 7.17B | -- | 6.67B | 7.45B | 3 |
FQ4 2026 (Oct 2026) | 6.37B | -- | 6.24B | 6.56B | 4 |
FQ3 2026 (Jul 2026) | 5.99B | -- | 5.86B | 6.16B | 4 |
FQ2 2026 (Jun 2026) | 6.34B | -- | 6.06B | 6.7B | 2 |
FQ1 2026 (Mar 2026) | 5.92B | -- | 5.65B | 6.25B | 2 |
FQ4 2025 (Oct 2025) | 5.76B | -5.14 | 5.64B | 5.93B | 2 |
FQ3 2025 (Jul 2025) | 5.43B | 12.32 | 5.31B | 5.59B | 2 |
FQ2 2025 (Jun 2025) | 5.09B | 9.7 | 4.86B | 5.37B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
0
EPS # of in-lines
3
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 12.6 | 12.6 | 100% | |
FQ3 2024 (Sep 2024) | 7.831 | 7.831 | 100% | |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 6.79 | 6.79 | 100% | |
FQ4 2023 (Dec 2023) | 3.25 | 3.25 | 100% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
FQ2 2023 (Jun 2023) | 5.22 | 5.22 | 100% | |
FQ1 2023 (Mar 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $6.06B | $6059M | 100% |
FQ3 2024 (Sep 2024) | $0B | $4.76B | $4760M | 100% |
FQ2 2024 (Jun 2024) | $0B | $4.59B | $4592M | 100% |
FQ1 2024 (Mar 2024) | $0B | $4.33B | $4333M | 100% |
FQ4 2023 (Dec 2023) | $0B | $4.26B | $4261M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.42B | $3419M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.42B | $3415M | 100% |
FQ1 2023 (Mar 2023) | $0B | $2.76B | $2763M | 100% |